Rivaroxaban triggered multifocal intratumoral hemorrhage of the cabozantinib-treated diffuse brain metastases: A case report and review of literature
Brain metastases (BMs) are the most common intracranial malignancy with poor prognosis. Patients with intracranial tumors are at greater risk for thrombotic complications and intracranial hemorrhage. Rivaroxaban is a potent oral anticoagulant with the high selectivity of direct factor Xa inhibition....
Guardado en:
Autores principales: | Chen Luyue, Chen E, Huang Yanlin, Tian Xinhua |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
De Gruyter
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fc7bba1ce001477ab657802a1b2163bf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Design and Baseline Data for a Prospective Observational Study of Rivaroxaban in Patients with Venous Thromboembolism in Japan (XASSENT)
por: Ikuo Fukuda, et al.
Publicado: (2021) -
Rivaroxaban in acute venous thromboembolism: UK prescribing experience
por: Victoria Speed, et al.
Publicado: (2021) -
Patients with venous thromboembolism after spontaneous intracerebral hemorrhage: a review
por: Qiyan Cai, et al.
Publicado: (2021) -
Benefit–Risk of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness: Pooled Analysis From MAGELLAN and MARINER
por: Gary E. Raskob, et al.
Publicado: (2021) -
Mean platelet volume as a prognostic factor for venous thromboembolic disease
por: Díaz,Juan Manuel, et al.
Publicado: (2019)